First-pass extracted concept

extracellular vesicles

Candidate: concept label5 source documents8 linked claims
Live refresh every 5sNext refresh in 5s

Aliases

EVs

Extracted Explainers

What the tool is doing

Extracellular vesicles are listed as a modern nanoplatform used in the sepsis nanomedicine landscape.

Source 1DOIPubMed

The source summary lists extracellular vesicles as an explicitly supported delivery-related component relevant to cancer gene delivery.

Source 2DOIPubMed

Evidence Snippets

modern nanoplatforms enhance this approach with biomimetic coatings, toxin nanosponges, and extracellular vesicles.
Evidence 1Source 1DOIPubMedprovenance
The editorial text also explicitly names supported related items such as oAd-SA, OX40L/PPT nanoparticles, oncolytic viruses, adenoviral vectors, AAVs, extracellular vesicles/exosomes, and DC-targeting lentivectors.
Evidence 2Source 2DOIPubMedprovenance
To investigate extracellular vesicles (EVs) as potential biomarkers for diagnosing and staging steatosis in patients with MASLD using machine learning (ML) and explainable artificial intelligence (XAI).
Evidence 3Source 3DOIPubMedprovenance
extracellular vesicles (EVs), a collective term covering various subtypes of cell-released, membranous structures
Evidence 4Source 4DOIPubMedprovenance
The article frames thermogenic failure as loss of beige/brown adipocyte cellular competence, emphasizing ... vesicle trafficking/extracellular vesicles.
Evidence 5Source 5provenance

Supporting Sources

Source 4primary paper2018Journal of Extracellular VesiclesDOIPubMed

Linked Claims

Claim 1mechanism of actionsupports2026Source 1DOIPubMed

Modern sepsis nanoplatforms including biomimetic coatings, toxin nanosponges, and extracellular vesicles can neutralize PAMPs and DAMPs, modulate TLR signaling, and reprogram macrophages with spatial and stimulus control.

Quoted textsource-backed
These tools neutralize Pathogen-associated molecular patterns (PAMPs) and danger-associated molecular patterns (DAMPs), modulate Toll-like receptor (TLR) signaling, and reprogram macrophages with spatial and stimulus control.
Claim 2platform evolutionsupports2026Source 1DOIPubMed

Early nanocarriers improved the pharmacokinetics of antibiotics and anti-inflammatory drugs, and modern nanoplatforms extend this approach with biomimetic coatings, toxin nanosponges, and extracellular vesicles.

Quoted textsource-backed
Early nanocarriers improved the pharmacokinetics of antibiotics and anti-inflammatory drugs, while modern nanoplatforms enhance this approach with biomimetic coatings, toxin nanosponges, and extracellular vesicles.
Claim 3combined feature benefitsupports2025Source 3DOIPubMed

Combining EV, clinical, and anthropomorphic features improved diagnostic accuracy for identifying severe steatosis compared with EV-only modeling aims described in the study.

Claim 4feature importancesupports2025Source 3DOIPubMed

EV mean size and concentration were key predictors for steatosis-stage classification in the study models.

Claim 5named examplesupports2025Source 2DOIPubMed

The editorial explicitly names oAd-SA, OX40L/PPT nanoparticles, extracellular vesicles or exosomes, and DC-targeting lentivectors as supported related items within the topic.

Claim 6field challengesupports2018Source 4DOIPubMed

Extracellular vesicles are difficult to obtain as relatively pure preparations and to characterize properly because of their size and amount.

Quoted textsource-backed
specific issues arise when working with these entities, whose size and amount often make them difficult to obtain as relatively pure preparations, and to characterize properly
Claim 7reporting requirementsupports2018Source 4DOIPubMed

Assigning specific functions to extracellular vesicles or EV subtypes requires reporting information beyond mere description of function in crude, potentially contaminated, heterogeneous preparations.

Quoted textsource-backed
ascribing a specific function to EVs in general, or to subtypes of EVs, requires reporting of specific information beyond mere description of function in a crude, potentially contaminated, and heterogeneous preparation
Claim 8mechanistic scopesupportsyear unknownSource 5

The source emphasizes mitochondrial capacity and quality control, intracellular signaling fidelity and cAMP compartmentation, vesicle trafficking and extracellular vesicles, and the effects of obesity and aging as components of thermogenic cellular competence.